Naturally Splendid Provides Default Status Report
VANCOUVER, BC / ACCESSWIRE / May 31, 2022 / Naturally Splendid Enterprises Ltd. (“Naturally Splendid” or “NSE” or the “Company” ) (FRANKFURT:50N) (TSXV:NSP) (OTC PINK:NSPDF) today is providing a status update in accordance with its more...
SHAREHOLDER ALERT: Weiss Law Reminds PCSB, WLL, SREV, and HMTV
SHAREHOLDER ALERT: Weiss Law Reminds PCSB, WLL, SREV, and HMTV PR Newswire NEW YORK , May 31, 2022 /PRNewswire/ — If you own shares in any of the companies listed above and would like to more...
AnPac Bio Reports 49.1% Decrease in Net Loss in First Quarter of Fiscal 2022
PHILADELPHIA, May 31, 2022 (GLOBE NEWSWIRE) — AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States, announced today its unaudited more...
Hepion Pharmaceuticals Urges Shareholders to Vote “FOR” All Proposals Ahead of its Upcoming Annual Meeting
EDISON, N.J., May 31, 2022 (GLOBE NEWSWIRE) — Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on Artificial Intelligence (“AI”)-driven therapeutic drug development for the treatment of non-alcoholic steatohepatitis (“NASH”) and hepatocellular carcinoma more...
Cansortium Reports First Quarter 2022 Financial Results
Cansortium Reports First Quarter 2022 Financial Results PR Newswire – Q1 Revenue up 30% YoY to a Record $19.7 Million ; Preliminary April Revenue of $7.5 Million – – Q1 Adjusted EBITDA up 42% YoY more...
Lightbridge to Participate at STHLM+50 Climate Hub
Panel to Focus on Achieving Energy Security While Meeting Climate Goals RESTON, Va., May 31, 2022 (GLOBE NEWSWIRE) — Lightbridge Corporation (Nasdaq: LTBR), an advanced nuclear fuel technology company, is pleased to announce that Lightbridge more...
Amicus’ (FOLD) Galafold Aids Growth, Overdependence a Woe
Amicus Therapeutics FOLD is focused on developing a diverse set of novel treatments for patients living with rare metabolic diseases. Currently, FOLD has only one marketed medicine in its portfolio called Galafold (migalastat), an oral more...
What Makes Adamis (ADMP) a New Buy Stock
Adamis Pharmaceuticals (ADMP) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most more...
GSK to Boost Vaccine Portfolio With Affinivax Acquisition
GSK plc GSK announced that it has entered into a definitive agreement with Massachusetts-based privately held biopharmaceutical company, Affinivax, Inc., wherein it will acquire the latter for an upfront payment of $2.1 billion. GSK will more...
Enochian Biosciences, Inc. Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm
BOSTON, MA / ACCESSWIRE / May 31, 2022 / Block & Leviton is investigating Enochian Biosciences, Inc. (NASDAQ:ENOB) for potential securities law violations. Investors who have lost money in their Enochian Biosciences, Inc. investment should more...